UniProtKB - O75096 (LRP4_HUMAN)
UniProt
O75096 - LRP4_HUMAN
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Low-density lipoprotein receptor-related protein 4
LRP4
Functioni
GO - Molecular functioni
- calcium ion binding Source: InterPro
- receptor tyrosine kinase binding Source: UniProtKB
- scaffold protein binding Source: UniProtKB
- Wnt-activated receptor activity Source: GO_Central
- Wnt-protein binding Source: GO_Central
GO - Biological processi
- BMP signaling pathway Source: InterPro
- canonical Wnt signaling pathway Source: GO_Central
- dendrite morphogenesis Source: UniProtKB
- embryonic digit morphogenesis Source: Ensembl
- endocytosis Source: UniProtKB-KW
- extracellular matrix organization Source: Reactome
- hair follicle development Source: Ensembl
- kidney development Source: UniProtKB
- limb development Source: UniProtKB
- negative regulation of axonogenesis Source: UniProtKB
- negative regulation of canonical Wnt signaling pathway Source: UniProtKB
- negative regulation of ossification Source: UniProtKB
- odontogenesis of dentin-containing tooth Source: Ensembl
- positive regulation of presynaptic membrane organization Source: UniProtKB
- postsynaptic membrane assembly Source: UniProtKB
- presynaptic membrane assembly Source: UniProtKB
- protein heterotetramerization Source: UniProtKB
- proximal/distal pattern formation Source: Ensembl
- regulation of protein phosphorylation Source: Ensembl
- skeletal muscle acetylcholine-gated channel clustering Source: UniProtKB
- synapse organization Source: UniProtKB
- synaptic growth at neuromuscular junction Source: UniProtKB
- Wnt signaling pathway involved in dorsal/ventral axis specification Source: GO_Central
Keywords - Molecular functioni
Developmental protein, ReceptorKeywords - Biological processi
Differentiation, Endocytosis, Wnt signaling pathwayKeywords - Ligandi
CalciumEnzyme and pathway databases
| Reactomei | REACT_163906. ECM proteoglycans. |
Names & Taxonomyi
| Protein namesi | Recommended name: Low-density lipoprotein receptor-related protein 4Short name: LRP-4 Alternative name(s): Multiple epidermal growth factor-like domains 7 |
| Gene namesi | Name:LRP4 Synonyms:KIAA0816, LRP10, MEGF7 |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi | UP000005640 Componenti: Chromosome 11 |
Organism-specific databases
| HGNCi | HGNC:6696. LRP4. |
Subcellular locationi
- Membrane Curated; Single-pass type I membrane protein Curated
Topology
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
|---|---|---|---|---|---|---|
| Topological domaini | 21 – 1725 | 1705 | ExtracellularSequence Analysis | Add BLAST | ||
| Transmembranei | 1726 – 1746 | 21 | HelicalSequence Analysis | Add BLAST | ||
| Topological domaini | 1747 – 1905 | 159 | CytoplasmicSequence Analysis | Add BLAST |
GO - Cellular componenti
- cell surface Source: UniProtKB
- dendrite Source: UniProtKB
- flotillin complex Source: Ensembl
- integral component of membrane Source: UniProtKB-KW
- neuromuscular junction Source: UniProtKB
- neuronal cell body Source: UniProtKB
- postsynaptic density Source: UniProtKB
- synaptic membrane Source: UniProtKB
Keywords - Cellular componenti
MembranePathology & Biotechi
Involvement in diseasei
Cenani-Lenz syndactyly syndrome (CLSS)1 Publication
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA congenital malformation syndrome defined as complete and complex syndactyly of the hands combined with malformations of the forearm bones and similar manifestations in the lower limbs. It is characterized by fusion and disorganization of metacarpal and phalangeal bones, radius and ulnar shortening, radioulnar synostosis, and severe syndactyly of hands and feet.
See also OMIM:212780| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
|---|---|---|---|---|---|---|
| Natural varianti | 137 – 137 | 1 | D → N in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063776 | ||
| Natural varianti | 160 – 160 | 1 | C → Y in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063777 | ||
| Natural varianti | 449 – 449 | 1 | D → N in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063778 | ||
| Natural varianti | 461 – 461 | 1 | T → P in CLSS. 1 Publication | VAR_063779 | ||
| Natural varianti | 473 – 473 | 1 | L → F in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063780 | ||
| Natural varianti | 529 – 529 | 1 | D → N in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063781 | ||
| Natural varianti | 1017 – 1017 | 1 | C → R in CLSS. 1 Publication | VAR_063782 |
Sclerosteosis 2 (SOST2)1 Publication
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA sclerosing bone dysplasia characterized by a generalized hyperostosis and sclerosis leading to a markedly thickened skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients.
See also OMIM:614305| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
|---|---|---|---|---|---|---|
| Natural varianti | 1170 – 1170 | 1 | R → W in SOST2; impairs the interaction with SOST; loss of function as facilitator of SOST-mediated inhibition of Wnt signaling. 1 Publication | VAR_066630 | ||
| Natural varianti | 1186 – 1186 | 1 | W → S in SOST2; impairs the interaction with SOST; loss of function as facilitator of SOST-mediated inhibition of Wnt signaling. 1 Publication | VAR_066631 |
Keywords - Diseasei
Disease mutationOrganism-specific databases
| MIMi | 212780. phenotype. 614305. phenotype. |
| Orphaneti | 3258. Cenani-Lenz syndrome. 98913. Postsynaptic congenital myasthenic syndromes. 3152. Sclerosteosis. |
| PharmGKBi | PA30454. |
Polymorphism and mutation databases
| BioMutai | LRP4. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
|---|---|---|---|---|---|---|
| Signal peptidei | 1 – 20 | 20 | Sequence Analysis | Add BLAST | ||
| Chaini | 21 – 1905 | 1885 | Low-density lipoprotein receptor-related protein 4 | PRO_0000017325 | Add BLAST |
Amino acid modifications
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
|---|---|---|---|---|---|---|
| Disulfide bondi | 27 ↔ 44 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 34 ↔ 57 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 51 ↔ 66 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 71 ↔ 83 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 78 ↔ 96 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 90 ↔ 105 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 110 ↔ 122 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 117 ↔ 135 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 129 ↔ 143 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 148 ↔ 160 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 155 ↔ 173 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 167 ↔ 182 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 191 ↔ 203 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 198 ↔ 216 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 210 ↔ 225 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 231 ↔ 243 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 238 ↔ 256 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 250 ↔ 265 | PROSITE-ProRule annotation | ||||
| Glycosylationi | 264 – 264 | 1 | N-linked (GlcNAc...)Sequence Analysis | |||
| Disulfide bondi | 270 ↔ 282 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 277 ↔ 295 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 289 ↔ 304 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 312 ↔ 324 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 319 ↔ 337 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 331 ↔ 349 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 358 ↔ 369 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 365 ↔ 378 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 380 ↔ 393 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 399 ↔ 409 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 405 ↔ 418 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 420 ↔ 433 | PROSITE-ProRule annotation | ||||
| Glycosylationi | 498 – 498 | 1 | N-linked (GlcNAc...)Sequence Analysis | |||
| Disulfide bondi | 702 ↔ 713 | PROSITE-ProRule annotation | ||||
| Disulfide bondi | 709 ↔ 722 | PROSITE-ProRule annotation | ||||
| Glycosylationi | 719 – 719 | 1 | N-linked (GlcNAc...)Sequence Analysis | |||
| Disulfide bondi | 724 ↔ 736 | PROSITE-ProRule annotation | ||||
| Glycosylationi | 901 – 901 | 1 | N-linked (GlcNAc...)Sequence Analysis | |||
| Glycosylationi | 1077 – 1077 | 1 | N-linked (GlcNAc...)Sequence Analysis | |||
| Glycosylationi | 1415 – 1415 | 1 | N-linked (GlcNAc...)Sequence Analysis | |||
| Glycosylationi | 1467 – 1467 | 1 | N-linked (GlcNAc...)Sequence Analysis |
Keywords - PTMi
Disulfide bond, GlycoproteinProteomic databases
| MaxQBi | O75096. |
| PaxDbi | O75096. |
| PRIDEi | O75096. |
PTM databases
| PhosphoSitei | O75096. |
Expressioni
Tissue specificityi
Gene expression databases
| Bgeei | O75096. |
| CleanExi | HS_LRP4. |
| ExpressionAtlasi | O75096. baseline and differential. |
| Genevisiblei | O75096. HS. |
Organism-specific databases
| HPAi | HPA011934. HPA012300. |
Interactioni
Subunit structurei
Binary interactionsi
| With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| SOST | Q9BQB4 | 4 | EBI-310873,EBI-5746563 |
Protein-protein interaction databases
| BioGridi | 110218. 15 interactions. |
| IntActi | O75096. 4 interactions. |
| STRINGi | 9606.ENSP00000367888. |
Structurei
3D structure databases
| ProteinModelPortali | O75096. |
| SMRi | O75096. Positions 27-1640. |
| ModBasei | Search... |
| MobiDBi | Search... |
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
|---|---|---|---|---|---|---|
| Domaini | 26 – 67 | 42 | LDL-receptor class A 1PROSITE-ProRule annotation | Add BLAST | ||
| Domaini | 70 – 106 | 37 | LDL-receptor class A 2PROSITE-ProRule annotation | Add BLAST | ||
| Domaini | 109 – 144 | 36 | LDL-receptor class A 3PROSITE-ProRule annotation | Add BLAST | ||
| Domaini | 147 – 183 | 37 | LDL-receptor class A 4PROSITE-ProRule annotation | Add BLAST | ||
| Domaini | 190 – 226 | 37 | LDL-receptor class A 5PROSITE-ProRule annotation | Add BLAST | ||
| Domaini | 230 – 266 | 37 | LDL-receptor class A 6PROSITE-ProRule annotation | Add BLAST | ||
| Domaini | 269 – 305 | 37 | LDL-receptor class A 7PROSITE-ProRule annotation | Add BLAST | ||
| Domaini | 311 – 350 | 40 | LDL-receptor class A 8PROSITE-ProRule annotation | Add BLAST | ||
| Domaini | 354 – 394 | 41 | EGF-like 1; calcium-bindingSequence Analysis | Add BLAST | ||
| Domaini | 395 – 434 | 40 | EGF-like 2; calcium-bindingSequence Analysis | Add BLAST | ||
| Repeati | 480 – 522 | 43 | LDL-receptor class B 1 | Add BLAST | ||
| Repeati | 523 – 565 | 43 | LDL-receptor class B 2 | Add BLAST | ||
| Repeati | 566 – 609 | 44 | LDL-receptor class B 3 | Add BLAST | ||
| Repeati | 610 – 652 | 43 | LDL-receptor class B 4 | Add BLAST | ||
| Repeati | 653 – 693 | 41 | LDL-receptor class B 5 | Add BLAST | ||
| Domaini | 698 – 737 | 40 | EGF-like 3 | Add BLAST | ||
| Repeati | 785 – 827 | 43 | LDL-receptor class B 6 | Add BLAST | ||
| Repeati | 828 – 870 | 43 | LDL-receptor class B 7 | Add BLAST | ||
| Repeati | 871 – 914 | 44 | LDL-receptor class B 8 | Add BLAST | ||
| Repeati | 915 – 956 | 42 | LDL-receptor class B 9 | Add BLAST | ||
| Repeati | 957 – 998 | 42 | LDL-receptor class B 10 | Add BLAST | ||
| Repeati | 1093 – 1135 | 43 | LDL-receptor class B 11 | Add BLAST | ||
| Repeati | 1136 – 1178 | 43 | LDL-receptor class B 12 | Add BLAST | ||
| Repeati | 1179 – 1222 | 44 | LDL-receptor class B 13 | Add BLAST | ||
| Repeati | 1223 – 1263 | 41 | LDL-receptor class B 14 | Add BLAST | ||
| Repeati | 1264 – 1306 | 43 | LDL-receptor class B 15 | Add BLAST | ||
| Repeati | 1397 – 1439 | 43 | LDL-receptor class B 16 | Add BLAST | ||
| Repeati | 1440 – 1482 | 43 | LDL-receptor class B 17 | Add BLAST | ||
| Repeati | 1483 – 1526 | 44 | LDL-receptor class B 18 | Add BLAST | ||
| Repeati | 1527 – 1568 | 42 | LDL-receptor class B 19 | Add BLAST | ||
| Repeati | 1569 – 1610 | 42 | LDL-receptor class B 20 | Add BLAST |
Motif
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
|---|---|---|---|---|---|---|
| Motifi | 1766 – 1769 | 4 | Endocytosis signalSequence Analysis |
Sequence similaritiesi
Keywords - Domaini
EGF-like domain, Repeat, Signal, Transmembrane, Transmembrane helixPhylogenomic databases
| eggNOGi | NOG235850. |
| GeneTreei | ENSGT00760000118968. |
| HOGENOMi | HOG000047507. |
| HOVERGENi | HBG049163. |
| InParanoidi | O75096. |
| OMAi | GSQLLWA. |
| OrthoDBi | EOG75XGK3. |
| PhylomeDBi | O75096. |
| TreeFami | TF315253. |
Family and domain databases
| Gene3Di | 2.120.10.30. 4 hits. 4.10.400.10. 8 hits. |
| InterProi | IPR011042. 6-blade_b-propeller_TolB-like. IPR026823. cEGF. IPR000742. EG-like_dom. IPR001881. EGF-like_Ca-bd_dom. IPR013032. EGF-like_CS. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR018097. EGF_Ca-bd_CS. IPR009030. Growth_fac_rcpt_N_dom. IPR023415. LDLR_class-A_CS. IPR000033. LDLR_classB_rpt. IPR002172. LDrepeatLR_classA_rpt. IPR030799. LRP4. [Graphical view] |
| PANTHERi | PTHR10529:SF196. PTHR10529:SF196. 1 hit. |
| Pfami | PF12662. cEGF. 1 hit. PF00057. Ldl_recept_a. 8 hits. PF00058. Ldl_recept_b. 16 hits. [Graphical view] |
| PRINTSi | PR00261. LDLRECEPTOR. |
| SMARTi | SM00181. EGF. 4 hits. SM00179. EGF_CA. 1 hit. SM00192. LDLa. 8 hits. SM00135. LY. 20 hits. [Graphical view] |
| SUPFAMi | SSF57184. SSF57184. 2 hits. SSF57424. SSF57424. 8 hits. |
| PROSITEi | PS00010. ASX_HYDROXYL. 1 hit. PS01186. EGF_2. 3 hits. PS01187. EGF_CA. 1 hit. PS01209. LDLRA_1. 8 hits. PS50068. LDLRA_2. 8 hits. PS51120. LDLRB. 20 hits. [Graphical view] |
Sequencei
Sequence statusi: Complete.
Sequence processingi: The displayed sequence is further processed into a mature form.
10 20 30 40 50
MRRQWGALLL GALLCAHGLA SSPECACGRS HFTCAVSALG ECTCIPAQWQ
60 70 80 90 100
CDGDNDCGDH SDEDGCILPT CSPLDFHCDN GKCIRRSWVC DGDNDCEDDS
110 120 130 140 150
DEQDCPPREC EEDEFPCQNG YCIRSLWHCD GDNDCGDNSD EQCDMRKCSD
160 170 180 190 200
KEFRCSDGSC IAEHWYCDGD TDCKDGSDEE NCPSAVPAPP CNLEEFQCAY
210 220 230 240 250
GRCILDIYHC DGDDDCGDWS DESDCSSHQP CRSGEFMCDS GLCINAGWRC
260 270 280 290 300
DGDADCDDQS DERNCTTSMC TAEQFRCHSG RCVRLSWRCD GEDDCADNSD
310 320 330 340 350
EENCENTGSP QCALDQFLCW NGRCIGQRKL CNGVNDCGDN SDESPQQNCR
360 370 380 390 400
PRTGEENCNV NNGGCAQKCQ MVRGAVQCTC HTGYRLTEDG HTCQDVNECA
410 420 430 440 450
EEGYCSQGCT NSEGAFQCWC ETGYELRPDR RSCKALGPEP VLLFANRIDI
460 470 480 490 500
RQVLPHRSEY TLLLNNLENA IALDFHHRRE LVFWSDVTLD RILRANLNGS
510 520 530 540 550
NVEEVVSTGL ESPGGLAVDW VHDKLYWTDS GTSRIEVANL DGAHRKVLLW
560 570 580 590 600
QNLEKPRAIA LHPMEGTIYW TDWGNTPRIE ASSMDGSGRR IIADTHLFWP
610 620 630 640 650
NGLTIDYAGR RMYWVDAKHH VIERANLDGS HRKAVISQGL PHPFAITVFE
660 670 680 690 700
DSLYWTDWHT KSINSANKFT GKNQEIIRNK LHFPMDIHTL HPQRQPAGKN
710 720 730 740 750
RCGDNNGGCT HLCLPSGQNY TCACPTGFRK ISSHACAQSL DKFLLFARRM
760 770 780 790 800
DIRRISFDTE DLSDDVIPLA DVRSAVALDW DSRDDHVYWT DVSTDTISRA
810 820 830 840 850
KWDGTGQEVV VDTSLESPAG LAIDWVTNKL YWTDAGTDRI EVANTDGSMR
860 870 880 890 900
TVLIWENLDR PRDIVVEPMG GYMYWTDWGA SPKIERAGMD ASGRQVIISS
910 920 930 940 950
NLTWPNGLAI DYGSQRLYWA DAGMKTIEFA GLDGSKRKVL IGSQLPHPFG
960 970 980 990 1000
LTLYGERIYW TDWQTKSIQS ADRLTGLDRE TLQENLENLM DIHVFHRRRP
1010 1020 1030 1040 1050
PVSTPCAMEN GGCSHLCLRS PNPSGFSCTC PTGINLLSDG KTCSPGMNSF
1060 1070 1080 1090 1100
LIFARRIDIR MVSLDIPYFA DVVVPINITM KNTIAIGVDP QEGKVYWSDS
1110 1120 1130 1140 1150
TLHRISRANL DGSQHEDIIT TGLQTTDGLA VDAIGRKVYW TDTGTNRIEV
1160 1170 1180 1190 1200
GNLDGSMRKV LVWQNLDSPR AIVLYHEMGF MYWTDWGENA KLERSGMDGS
1210 1220 1230 1240 1250
DRAVLINNNL GWPNGLTVDK ASSQLLWADA HTERIEAADL NGANRHTLVS
1260 1270 1280 1290 1300
PVQHPYGLTL LDSYIYWTDW QTRSIHRADK GTGSNVILVR SNLPGLMDMQ
1310 1320 1330 1340 1350
AVDRAQPLGF NKCGSRNGGC SHLCLPRPSG FSCACPTGIQ LKGDGKTCDP
1360 1370 1380 1390 1400
SPETYLLFSS RGSIRRISLD TSDHTDVHVP VPELNNVISL DYDSVDGKVY
1410 1420 1430 1440 1450
YTDVFLDVIR RADLNGSNME TVIGRGLKTT DGLAVDWVAR NLYWTDTGRN
1460 1470 1480 1490 1500
TIEASRLDGS CRKVLINNSL DEPRAIAVFP RKGYLFWTDW GHIAKIERAN
1510 1520 1530 1540 1550
LDGSERKVLI NTDLGWPNGL TLDYDTRRIY WVDAHLDRIE SADLNGKLRQ
1560 1570 1580 1590 1600
VLVSHVSHPF ALTQQDRWIY WTDWQTKSIQ RVDKYSGRNK ETVLANVEGL
1610 1620 1630 1640 1650
MDIIVVSPQR QTGTNACGVN NGGCTHLCFA RASDFVCACP DEPDSRPCSL
1660 1670 1680 1690 1700
VPGLVPPAPR ATGMSEKSPV LPNTPPTTLY SSTTRTRTSL EEVEGRCSER
1710 1720 1730 1740 1750
DARLGLCARS NDAVPAAPGE GLHISYAIGG LLSILLILVV IAALMLYRHK
1760 1770 1780 1790 1800
KSKFTDPGMG NLTYSNPSYR TSTQEVKIEA IPKPAMYNQL CYKKEGGPDH
1810 1820 1830 1840 1850
NYTKEKIKIV EGICLLSGDD AEWDDLKQLR SSRGGLLRDH VCMKTDTVSI
1860 1870 1880 1890 1900
QASSGSLDDT ETEQLLQEEQ SECSSVHTAA TPERRGSLPD TGWKHERKLS
SESQV
Sequence cautioni
Experimental Info
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
|---|---|---|---|---|---|---|
| Sequence conflicti | 1472 – 1475 | 4 | EPRA → D in BAE19679 (PubMed:9693030).Curated | |||
| Sequence conflicti | 1478 – 1478 | 1 | V → A in BAE19679 (PubMed:9693030).Curated | |||
| Sequence conflicti | 1862 – 1862 | 1 | T → M in BAD83615 (Ref. 1) Curated | |||
| Sequence conflicti | 1862 – 1862 | 1 | T → M in BAA32468 (PubMed:9693030).Curated |
Natural variant
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
|---|---|---|---|---|---|---|
| Natural varianti | 137 – 137 | 1 | D → N in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063776 | ||
| Natural varianti | 160 – 160 | 1 | C → Y in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063777 | ||
| Natural varianti | 314 – 314 | 1 | L → S. Corresponds to variant rs7926667 [ dbSNP | Ensembl ]. | VAR_058290 | ||
| Natural varianti | 449 – 449 | 1 | D → N in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063778 | ||
| Natural varianti | 461 – 461 | 1 | T → P in CLSS. 1 Publication | VAR_063779 | ||
| Natural varianti | 473 – 473 | 1 | L → F in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063780 | ||
| Natural varianti | 529 – 529 | 1 | D → N in CLSS; abolishes the antagonistic effect of LRP4 on LRP6-mediated activation of Wnt signaling. 1 Publication | VAR_063781 | ||
| Natural varianti | 1017 – 1017 | 1 | C → R in CLSS. 1 Publication | VAR_063782 | ||
| Natural varianti | 1086 – 1086 | 1 | I → V.3 Publications Corresponds to variant rs6485702 [ dbSNP | Ensembl ]. | VAR_057955 | ||
| Natural varianti | 1170 – 1170 | 1 | R → W in SOST2; impairs the interaction with SOST; loss of function as facilitator of SOST-mediated inhibition of Wnt signaling. 1 Publication | VAR_066630 | ||
| Natural varianti | 1186 – 1186 | 1 | W → S in SOST2; impairs the interaction with SOST; loss of function as facilitator of SOST-mediated inhibition of Wnt signaling. 1 Publication | VAR_066631 | ||
| Natural varianti | 1203 – 1203 | 1 | A → V. Corresponds to variant rs2306033 [ dbSNP | Ensembl ]. | VAR_058291 | ||
| Natural varianti | 1238 – 1238 | 1 | A → T. Corresponds to variant rs2306031 [ dbSNP | Ensembl ]. | VAR_058292 | ||
| Natural varianti | 1554 – 1554 | 1 | S → G.3 Publications Corresponds to variant rs2306029 [ dbSNP | Ensembl ]. | VAR_057956 | ||
| Natural varianti | 1646 – 1646 | 1 | R → Q.3 Publications Corresponds to variant rs3816614 [ dbSNP | Ensembl ]. | VAR_057957 |
Sequence databases
|
Select the link destinations: EMBLi GenBanki DDBJi Links Updated | AB084910 mRNA. Translation: BAD83615.1. AB011540 mRNA. Translation: BAA32468.1. AB231861 mRNA. Translation: BAE19679.1. Different initiation. AC021573 Genomic DNA. No translation available. BC037360 mRNA. Translation: AAH37360.1. BC041048 mRNA. Translation: AAH41048.1. BC136667 mRNA. Translation: AAI36668.1. BC136668 mRNA. Translation: AAI36669.1. |
| CCDSi | CCDS31478.1. |
| RefSeqi | NP_002325.2. NM_002334.3. |
| UniGenei | Hs.4930. |
Genome annotation databases
| Ensembli | ENST00000378623; ENSP00000367888; ENSG00000134569. |
| GeneIDi | 4038. |
| KEGGi | hsa:4038. |
| UCSCi | uc001ndn.4. human. |
Keywords - Coding sequence diversityi
PolymorphismCross-referencesi
Sequence databases
|
Select the link destinations: EMBLi GenBanki DDBJi Links Updated | AB084910 mRNA. Translation: BAD83615.1. AB011540 mRNA. Translation: BAA32468.1. AB231861 mRNA. Translation: BAE19679.1. Different initiation. AC021573 Genomic DNA. No translation available. BC037360 mRNA. Translation: AAH37360.1. BC041048 mRNA. Translation: AAH41048.1. BC136667 mRNA. Translation: AAI36668.1. BC136668 mRNA. Translation: AAI36669.1. |
| CCDSi | CCDS31478.1. |
| RefSeqi | NP_002325.2. NM_002334.3. |
| UniGenei | Hs.4930. |
3D structure databases
| ProteinModelPortali | O75096. |
| SMRi | O75096. Positions 27-1640. |
| ModBasei | Search... |
| MobiDBi | Search... |
Protein-protein interaction databases
| BioGridi | 110218. 15 interactions. |
| IntActi | O75096. 4 interactions. |
| STRINGi | 9606.ENSP00000367888. |
PTM databases
| PhosphoSitei | O75096. |
Polymorphism and mutation databases
| BioMutai | LRP4. |
Proteomic databases
| MaxQBi | O75096. |
| PaxDbi | O75096. |
| PRIDEi | O75096. |
Protocols and materials databases
| Structural Biology Knowledgebase | Search... |
Genome annotation databases
| Ensembli | ENST00000378623; ENSP00000367888; ENSG00000134569. |
| GeneIDi | 4038. |
| KEGGi | hsa:4038. |
| UCSCi | uc001ndn.4. human. |
Organism-specific databases
| CTDi | 4038. |
| GeneCardsi | GC11M049899. |
| H-InvDB | HIX0009607. |
| HGNCi | HGNC:6696. LRP4. |
| HPAi | HPA011934. HPA012300. |
| MIMi | 212780. phenotype. 604270. gene. 614305. phenotype. |
| neXtProti | NX_O75096. |
| Orphaneti | 3258. Cenani-Lenz syndrome. 98913. Postsynaptic congenital myasthenic syndromes. 3152. Sclerosteosis. |
| PharmGKBi | PA30454. |
| HUGEi | Search... |
| GenAtlasi | Search... |
Phylogenomic databases
| eggNOGi | NOG235850. |
| GeneTreei | ENSGT00760000118968. |
| HOGENOMi | HOG000047507. |
| HOVERGENi | HBG049163. |
| InParanoidi | O75096. |
| OMAi | GSQLLWA. |
| OrthoDBi | EOG75XGK3. |
| PhylomeDBi | O75096. |
| TreeFami | TF315253. |
Enzyme and pathway databases
| Reactomei | REACT_163906. ECM proteoglycans. |
Miscellaneous databases
| ChiTaRSi | LRP4. human. |
| GeneWikii | Low_density_lipoprotein_receptor-related_protein_4. |
| GenomeRNAii | 4038. |
| NextBioi | 15818. |
| PROi | O75096. |
| SOURCEi | Search... |
Gene expression databases
| Bgeei | O75096. |
| CleanExi | HS_LRP4. |
| ExpressionAtlasi | O75096. baseline and differential. |
| Genevisiblei | O75096. HS. |
Family and domain databases
| Gene3Di | 2.120.10.30. 4 hits. 4.10.400.10. 8 hits. |
| InterProi | IPR011042. 6-blade_b-propeller_TolB-like. IPR026823. cEGF. IPR000742. EG-like_dom. IPR001881. EGF-like_Ca-bd_dom. IPR013032. EGF-like_CS. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR018097. EGF_Ca-bd_CS. IPR009030. Growth_fac_rcpt_N_dom. IPR023415. LDLR_class-A_CS. IPR000033. LDLR_classB_rpt. IPR002172. LDrepeatLR_classA_rpt. IPR030799. LRP4. [Graphical view] |
| PANTHERi | PTHR10529:SF196. PTHR10529:SF196. 1 hit. |
| Pfami | PF12662. cEGF. 1 hit. PF00057. Ldl_recept_a. 8 hits. PF00058. Ldl_recept_b. 16 hits. [Graphical view] |
| PRINTSi | PR00261. LDLRECEPTOR. |
| SMARTi | SM00181. EGF. 4 hits. SM00179. EGF_CA. 1 hit. SM00192. LDLa. 8 hits. SM00135. LY. 20 hits. [Graphical view] |
| SUPFAMi | SSF57184. SSF57184. 2 hits. SSF57424. SSF57424. 8 hits. |
| PROSITEi | PS00010. ASX_HYDROXYL. 1 hit. PS01186. EGF_2. 3 hits. PS01187. EGF_CA. 1 hit. PS01209. LDLRA_1. 8 hits. PS50068. LDLRA_2. 8 hits. PS51120. LDLRB. 20 hits. [Graphical view] |
| ProtoNeti | Search... |
Publicationsi
- "Low density lipoprotein receptor-related protein 10."
Ishikawa K., Fujimoto H., Kim D., Saeki S.
Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databasesCited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS VAL-1086; GLY-1554 AND GLN-1646.Tissue: Brain. - "Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening."
Nakayama M., Nakajima D., Nagase T., Nomura N., Seki N., Ohara O.
Genomics 51:27-34(1998) [PubMed] [Europe PMC] [Abstract]Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS VAL-1086; GLY-1554 AND GLN-1646.Tissue: Brain. - "Human chromosome 11 DNA sequence and analysis including novel gene identification."
Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.
Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract]Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. - "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS VAL-1086; GLY-1554 AND GLN-1646.Tissue: Muscle. - "LRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome."
Li Y., Pawlik B., Elcioglu N., Aglan M., Kayserili H., Yigit G., Percin F., Goodman F., Nurnberg G., Cenani A., Urquhart J., Chung B.D., Ismail S., Amr K., Aslanger A.D., Becker C., Netzer C., Scambler P. Wollnik B.
Am. J. Hum. Genet. 86:696-706(2010) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN THE REGULATION OF CANONICAL WTN SIGNALING, VARIANTS CLSS ASN-137; TYR-160; ASN-449; PRO-461; PHE-473; ASN-529 AND ARG-1017, CHARACTERIZATION OF VARIANTS CLSS ASN-137; TYR-160; ASN-449; PHE-473 AND ASN-529. - "Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function."
Leupin O., Piters E., Halleux C., Hu S., Kramer I., Morvan F., Bouwmeester T., Schirle M., Bueno-Lozano M., Fuentes F.J., Itin P.H., Boudin E., de Freitas F., Jennes K., Brannetti B., Charara N., Ebersbach H., Geisse S. Kneissel M.
J. Biol. Chem. 286:19489-19500(2011) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INTERACTION WITH SOST, TISSUE SPECIFICITY, VARIANTS SOST2 TRP-1170 AND SER-1186, CHARACTERIZATION OF VARIANTS SOST2 TRP-1170 AND SER-1186, IDENTIFICATION BY MASS SPECTROMETRY.
Entry informationi
| Entry namei | LRP4_HUMAN | ||||||||
| Accessioni | O75096Primary (citable) accession number: O75096 Secondary accession number(s): B2RN39, Q4AC85, Q5KTZ5 | ||||||||
| Entry historyi |
| ||||||||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Miscellaneousi
Keywords - Technical termi
Complete proteome, Reference proteomeDocuments
- Human chromosome 11Human chromosome 11: entries, gene names and cross-references to MIM
- Human entries with polymorphisms or disease mutationsList of human entries with polymorphisms or disease mutations
- Human polymorphisms and disease mutationsIndex of human polymorphisms and disease mutations
- MIM cross-referencesOnline Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
- SIMILARITY commentsIndex of protein domains and families
External Data
Dasty 3Similar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into Uniref entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |